EUCTR2005-004602-86-AT进行中（未招募）1 期
A comparison of crystalloids vs. colloids for intraoperative goal-directed fluid management - Crystalloids vs. colloids during surgery
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 1,112
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •After IRB approval and written informed consent patients aged 18 to 80 and scheduled for elective open abdominal surgery, open hysterectomy or myomectomy, or open urologic surgery (open prostatectomies and open cystectomies with ileal conduit formation) will be included in the study. Patients will be assigned to two groups:
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
- •After IRB approval and written informed consent patients aged 18 to 80 and scheduled for elective open abdominal surgery, open hysterectomy or myomectomy, or open urologic surgery (open prostatectomies and open cystectomies with ileal conduit formation) will be included in the study. Patients will be assigned to two groups:
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
- •After IRB approval and written informed consent patients aged 18 to 80 and scheduled for elective open abdominal surgery, open hysterectomy or myomectomy, or open urologic surgery (open prostatectomies and open cystectomies with ileal conduit formation) will be included in the study. Patients will be assigned to two groups:
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •We will exclude patients having cardiac (EF<35%) or renal insufficiency (creatinine clearance < 30ml/min, or on renal replacement therapy), coronary (NYHA IV) or peripheral artery disease, COPD, coagulopathies, symptoms of infection or sepsis, or a history of susceptibility to malignant hyperthermia or porphyria. Participants in other studies will be excluded, when an interference of the studies cannot be ruled out. Operating Room records indicate that sufficient qualifying patients will be available to complete the proposed studies within the requested timetable.
- •We will exclude patients having cardiac (EF<35%) or renal insufficiency (creatinine clearance < 30ml/min, or on renal replacement therapy), coronary (NYHA IV) or peripheral artery disease, COPD, coagulopathies, symptoms of infection or sepsis, or a history of susceptibility to malignant hyperthermia or porphyria. Participants in other studies will be excluded, when an interference of the studies cannot be ruled out. Operating Room records indicate that sufficient qualifying patients will be available to complete the proposed studies within the requested timetable.
- •We will exclude patients having cardiac (EF<35%) or renal insufficiency (creatinine clearance < 30ml/min, or on renal replacement therapy), coronary (NYHA IV) or peripheral artery disease, COPD, coagulopathies, symptoms of infection or sepsis, or a history of susceptibility to malignant hyperthermia or porphyria. Participants in other studies will be excluded, when an interference of the studies cannot be ruled out. Operating Room records indicate that sufficient qualifying patients will be available to complete the proposed studies within the requested timetable.
研究者
相似试验
已完成
不适用
Comparison of two different types of fluids on blood clotting parameters in patients undergoing neurosurgical proceduresCTRI/2022/02/040513PGIMER110
已完成
3 期
comparison of crystalloid and colloid solutions effect on clot formation time and clot firmness after 10 minutes during the upper or lower limbs surgeriesCondition 1: clot firmness after 10 minutes. Condition 2: clot formation time.Haemorrhagic condition, unspecifiedConsumption coagulopathyIRCT201210223773N6Tehran University of Medical Sciences, Medical Faculty30
尚未招募
4 期
Comparison co-load colloid versus crystalloid to prevent hypotension in the patients undergoing hip or proximal femoral fracture surgery: a randomized controlled trialPatients with hip or proximal fracture undergoing spinal anesthesiaTCTR20210316007Faculty of Medicine, Prince of Songkla University80
已完成
4 期
Balanced crystalloids versus balanced colloids within a goal-directed haemodynamic protocol in patients undergoing gynaecological tumour resectioISRCTN53154834Charité - University Medicine Berlin (Charité - Universitätsmedizin Berlin) (Germany)50
进行中（未招募）
不适用
Balanced crystalloids versus balanced colloids within a goal-directed hemodynamic protocol in patients undergoing gynaecological tumor resection.Balancierte Kristalloide versus balancierte Kolloide im Rahmen eines zielgerichteten Hämodynamik-Protokolls bei Patientinnen zur gynäkologischen TumoroperatioThe drugs Jonsteril and Volulyte6% will be investigated in female patients undergoing a tumor reduction operation. The study population will be female patients with metastatic ovarian carcinoma. The study medication will be administered and maintained according to a goal-directed hemodynamic protocol using an oesophagela Doppler during the operation.EUCTR2008-006135-12-DECharité- University Medicine Berlin